Citation Impact
Citing Papers
Preferential Generation of Follicular B Helper T Cells from Foxp3 + T Cells in Gut Peyer's Patches
2009 StandoutScienceNobel
A Novel, Fully Human Anti–fucosyl-GM1 Antibody Demonstrates Potent In Vitro and In Vivo Antitumor Activity in Preclinical Models of Small Cell Lung Cancer
2018
Humanization of an Anti-CCR4 Antibody That Kills Cutaneous T-Cell Lymphoma Cells and Abrogates Suppression by T-Regulatory Cells
2012
Intracellular Tumor-Associated Antigens Represent Effective Targets for Passive Immunotherapy
2012 StandoutNobel
Global analysis of protein folding using massively parallel design, synthesis, and testing
2017 StandoutScienceNobel
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
2013 StandoutNobel
Highly Recurrent TERT Promoter Mutations in Human Melanoma
2013 StandoutScience
Origins of catalysis by computationally designed retroaldolase enzymes
2010 StandoutNobel
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
2005 StandoutScience
An anti-CTLA-4 heavy chain–only antibody with enhanced T reg depletion shows excellent preclinical efficacy and safety profile
2022
Natural display of nuclear-encoded RNA on the cell surface and its impact on cell interaction
2020
The ϕPA3 phage nucleus is enclosed by a self-assembling 2D crystalline lattice
2023 StandoutNobel
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
2017 StandoutNobel
EGFR Antagonists in Cancer Treatment
2008 Standout
Complement and cellular cytotoxicity in antibody therapy of cancer
2008
Tumor‐Derived Exosomes in Immunosuppression and Immunotherapy
2020
Potential energy functions for protein design
2007
An Acquired and Endogenous Glycocalyx Forms a Bidirectional “Don’t Eat” and “Don’t Eat Me” Barrier to Phagocytosis
2020 StandoutNobel
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Comparing antibody and small-molecule therapies for cancer
2006
Molecular biology of the Ets family of transcription factors
2003
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Antibody engineering and modification technologies
2007
A 50-Year Personal Journey: Location, Gene Expression, and Circadian Rhythms
2017 StandoutNobel
Computational Enzyme Design
2013 StandoutNobel
Distinguishing between resistance, tolerance and persistence to antibiotic treatment
2016
The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression
2000 Standout
High‐throughput, subpixel precision analysis of bacterial morphogenesis and intracellular spatio‐temporal dynamics
2011
Progress in computational protein design
2007
Design of Protein–Ligand Binding Based on the Molecular-Mechanics Energy Model
2008
Monoclonal antibodies: versatile platforms for cancer immunotherapy
2010
Tau in physiology and pathology
2015 Standout
Fcγ receptors as regulators of immune responses
2007 Standout
Atomic accuracy in predicting and designing noncanonical RNA structure
2010 StandoutNobel
Follicular B helper T cells in antibody responses and autoimmunity
2005
Therapeutic antibodies for autoimmunity and inflammation
2010
Antibody therapy of cancer
2012 Standout
Epithelial–mesenchymal transitions in tumour progression
2002 Standout
Natural Killer Cell Mediated Antibody-Dependent Cellular Cytotoxicity in Tumor Immunotherapy with Therapeutic Antibodies
2013
Biofilms: an emergent form of bacterial life
2016 Standout
Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies
2016
Novel asymmetrically engineered antibody Fc variant with superior FcγR binding affinity and specificity compared with afucosylated Fc variant
2013
Antibody-Based Vascular Tumor Targeting
2009
Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities
2010 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Molecular mechanisms of T cell co-stimulation and co-inhibition
2013 Standout
Activation‐Induced Cytidine Deaminase Links Class Switch Recombination and Somatic Hypermutation
2003 StandoutNobel
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
Macrophages are critical effectors of antibody therapies for cancer
2015
Antibody Uptake into Neurons Occurs Primarily via Clathrin-dependent Fcγ Receptor Endocytosis and Is a Prerequisite for Acute Tau Protein Clearance
2013
Factors and Forces Controlling V(D)J Recombination
2001
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
The trinity of COVID-19: immunity, inflammation and intervention
2020 Standout
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
2008 Standout
Properties of Human IgG1s Engineered for Enhanced Binding to the Neonatal Fc Receptor (FcRn)
2006
IgG4-related disease
2014 Standout
Design of next-generation protein therapeutics
2010
Interleukin 10 inhibits cytokine production of human AML cells
1996
Regulation of E-Cadherin Gene Expression during Tumor Progression: The Role of a New Ets-Binding Site and the E-pal Element
1999
Reassessment of Exosome Composition
2019 Standout
FcRn: the neonatal Fc receptor comes of age
2007 Standout
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Antibodies, Fc receptors and cancer
2007
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
NEW EMBO MEMBERS REVIEW: Transcriptional control by the TGF-beta/Smad signaling system
2000 Standout
Microfluidics: reframing biological enquiry
2015
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Integrated signalling pathways for mast-cell activation
2006 Standout
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Differential Regulation of Epithelial and Mesenchymal Markers by δEF1 Proteins in Epithelial–Mesenchymal Transition Induced by TGF-β
2007
Transplantability of a circadian clock to a noncircadian organism
2015
Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodies
2006
Bacterial scaffold directs pole-specific centromere segregation
2014 StandoutNobel
Transcriptional Activation by ETS and Leucine Zipper-Containing Basic Helix-Loop-Helix Proteins
1999
Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis [see comments]
1995
Role of PU.1 in Hematopoiesis
1998
IL-17 and Th17 Cells
2009 Standout
In vivo biotinylation of the vasculature in B-cell lymphoma identifies BST-2 as a target for antibody-based therapy
2009
Encapsulins: molecular biology of the shell
2017
Toward Accurate Screening in Computer-Aided Enzyme Design
2009 StandoutNobel
Challenges in the computational design of proteins
2009
Macromolecular Modeling with Rosetta
2008 StandoutNobel
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Sizing the Protein Translocation Pathway of Colicin Ia Channels
2003
Regulatory roles of IL-10–producing human follicular T cells
2019 StandoutNobel
Engineering human hematopoietic stem/progenitor cells to produce a broadly neutralizing anti-HIV antibody after in vitro maturation to human B lymphocytes.
2008 Nobel
Modern Technologies for Creating Synthetic Antibodies for Clinical Application
2009
Energy Functions in De Novo Protein Design: Current Challenges and Future Prospects
2013
Emerging Droplet Microfluidics
2017 Standout
Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene.
1999
IL-10 Inhibits FcεRI Expression in Mouse Mast Cells
2004
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody
2018 StandoutNobel
Works of Wei Dang being referenced
Optimization of antibody binding to FcγRIIa enhances macrophage phagocytosis of tumor cells
2008
Engineered antibody Fc variants with enhanced effector function
2006
Robust Growth of Escherichia coli
2010
A Three-protein-DNA Complex on a B Cell-specific Domain of the Immunoglobulin μ Heavy Chain Gene Enhancer
1997
The role of exosomal noncoding RNAs in cancer
2019
Interleukin-10 promotes the growth of megakaryocyte, mast cell, and multilineage colonies: analysis with committed progenitors and Thy1loSca1+ stem cells.
1994
Interaction of Ca 2+ -activated K + Channels with Refolded Charybdotoxins Mutated at a Central Interaction Residue
1996
ETS-Mediated Cooperation between Basic Helix-Loop-Helix Motifs of the Immunoglobulin μ Heavy-Chain Gene Enhancer
1998